|
SRGAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.668800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.425400E-01 |
| Normal-vs-Stage2 |
3.048200E-01 |
| Normal-vs-Stage3 |
3.976800E-01 |
| Normal-vs-Stage4 |
3.093800E-01 |
| Stage1-vs-Stage2 |
3.325400E-01 |
| Stage1-vs-Stage3 |
5.113400E-01 |
| Stage1-vs-Stage4 |
2.057000E-01 |
| Stage2-vs-Stage3 |
6.557000E-01 |
| Stage2-vs-Stage4 |
1.009790E-01 |
| Stage3-vs-Stage4 |
1.201600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.065800E-01 |
| Normal-vs-AfricanAmerican |
7.376400E-02 |
| Normal-vs-Asian |
1.077770E-01 |
| Caucasian-vs-AfricanAmerican |
5.710100E-02 |
| Caucasian-vs-Asian |
9.560100E-03 |
| AfricanAmerican-vs-Asian |
3.436700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.361200E-01 |
| Normal-vs-Female |
8.774600E-01 |
| Male-vs-Female |
8.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.770600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.905800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.036200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.899680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.524400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.586200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.396990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.770800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.319890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.420800E-01 |
| Normal-vs-Grade 2 |
9.300800E-01 |
| Normal-vs-Grade 3 |
3.643600E-01 |
| Normal-vs-Grade 4 |
3.606400E-01 |
| Grade 1-vs-Grade 2 |
8.280800E-01 |
| Grade 1-vs-Grade 3 |
9.152400E-01 |
| Grade 1-vs-Grade 4 |
3.666800E-01 |
| Grade 2-vs-Grade 3 |
3.521800E-01 |
| Grade 2-vs-Grade 4 |
3.181600E-01 |
| Grade 3-vs-Grade 4 |
1.418830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.749600E-01 |
| Normal-vs-ccB subtype |
4.544000E-01 |
| ccA subtype-vs-ccB subtype |
5.727600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.416200E-01 |
| Normal-vs-N1 |
1.333800E-01 |
| N0-vs-N1 |
1.281210E-01 |
|
|
